Brief: Idera Pharmaceuticals Reports QTRLY Loss Per Share Of $0.14

Aceragen

29/04/2021 21:32

April 29 (Reuters) - Idera Pharmaceuticals Inc  IDRA.O :
    * IDERA PHARMACEUTICALS REPORTS FIRST QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * IDERA PHARMACEUTICALS INC - QTRLY  LOSS PER SHARE $0.14
    * IDERA PHARMACEUTICALS INC - IN APRIL 2021, INITIATED
REDUCTION
IN FORCE THAT WILL IMPACT ABOUT 50% WORKFORCE BY MAY 31, 2021

Source text for Eikon:  ID:nGNX8PtH5 
Further company coverage:  IDRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))